Left Ventricular Hypertrophy
Information
- Disease name
- Left Ventricular Hypertrophy
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05726695 | Active, not recruiting | The Use of Blood Biochemical Markers for Diagnostics of Heart Muscle Diseases | June 1, 2018 | December 31, 2023 | |
| NCT00001632 | Completed | Investigation Into the Use of Ultrasound Technique in the Evaluation of Heart Disease | September 1997 | August 2002 | |
| NCT00001878 | Completed | Factors Contributing to Increased Left Ventricle Size in Patients With Abnormally Enlarged Hearts | February 1999 | August 2002 | |
| NCT00067665 | Completed | N/A | Hypertension in Hemodialysis | August 2003 | June 2008 |
| NCT00139555 | Completed | Phase 4 | Effects of Amlodipine/Benazepril in Reducing Left Ventricular Hypertrophy in Patients With High Risk Hypertension | July 2004 | November 2006 |
| NCT00219141 | Completed | Phase 3 | Aliskiren in Combination With Losartan Compared to Losartan on the Regression of Left Ventricular Hypertrophy in Overweight Patients With Essential Hypertension | October 2005 | November 2007 |
| NCT00688480 | Completed | Phase 4 | Do Xanthine Oxidase Inhibitors Reduce Both Left Ventricular Hypertrophy and Endothelial Dysfunction in Cardiovascular Patients With Renal Dysfunction? | January 2008 | February 2010 |
| NCT00368147 | Completed | Access Creation for Hemodialysis: Association With Structural Changes of the Heart | April 2002 | February 2007 | |
| NCT00497146 | Completed | Phase 3 | The PRIMO Study: Paricalcitol Capsules Benefits Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease Stage 3/4 | February 2008 | March 2012 |
| NCT00518479 | Completed | N/A | Pathophysiological Mechanisms of Hypertensive LVH:Optimising Regression | September 2003 | April 2004 |
| NCT00602004 | Completed | N/A | Attenuation of Cardiac Effects of Arteriovenous Fistula Creation With Losartan | October 2006 | December 2014 |
| NCT00607633 | Completed | Candesartan and Candesartan/ Hydrochlorothiazide in the Treatment of Patients With Hypertension and LVH | January 2007 | October 2007 | |
| NCT00001534 | Completed | Long Term Effects of Enalapril and Losartan on Genetic Heart Disease | September 1996 | April 2003 | |
| NCT00718848 | Completed | Impact of In-centre Nocturnal Hemodialysis on Ventricular Remodeling and Function in End-stage Renal Disease | July 2008 | December 2012 | |
| NCT00974857 | Completed | Phase 4 | Effects Of Volume Control Guided by Body Composition Monitor (BCM) on Blood Pressure and Cardiac Condition in Hemodialysis Patients | June 2009 | September 2010 |
| NCT00985322 | Completed | Phase 3 | Angiotensin-converting-enzyme (ACE) Inhibitors in Hemodialysis | May 2009 | April 2016 |
| NCT01198899 | Completed | Belgian Screening Project for the Detection of Anderson-Fabry Disease in Hypertrophic Cardiomyopathy | July 2009 | August 2011 | |
| NCT01360476 | Completed | N/A | Vitamin D Therapy to Reduce Cardiac Damage Among Vulnerable Hypertensive Patients | August 2011 | November 2015 |
| NCT01425411 | Completed | Phase 4 | Effect of Valsartan on Left Ventricular Myocardial Functions in Hypertensive Patients With Left Ventricular Hypertrophy | November 2006 | November 2008 |
| NCT01442116 | Completed | N/A | Evaluation of Regional Myocardial Dynamics at Physical Stress in Essential Hypertension | June 2009 | December 2009 |
| NCT01455974 | Completed | N/A | The Effects of Lowering Dialysate Sodium in Hypertensive Hemodialysis Patients | October 2010 | September 2011 |
| NCT01481298 | Completed | Value of Cardiac Magnetic Resonance (CMR) Derived Parameters for Diagnosing Left Ventricular Non-compaction Cardiomyopathy | December 2004 | October 2008 | |
| NCT01579032 | Completed | Pulse Wave Analysis and Velocity in Patients With Chronic Renal Failure: a Cross-sectional Observational Study to Assess Association With Left Ventricular Hypertrophy, Uremic Toxins and Inflammation. | January 2004 | January 2012 | |
| NCT01951404 | Completed | Phase 4 | Does ALlopurinol Regress lefT Ventricular Hypertrophy in End Stage REnal Disease: The ALTERED Study | September 2013 | August 2016 |
| NCT02226510 | Completed | Phase 4 | MetfoRmin and Its Effects on Left Ventricular Hypertrophy in Normotensive Patients With Coronary Artery Disease | March 2015 | December 2017 |
| NCT02295176 | Completed | N/A | Metabolic and Cardiovascular Effects of Armolipid Plus in Subjects With Metabolic Syndrome | April 2013 | July 2015 |
| NCT02684773 | Completed | In-Centre Nocturnal Hemodialysis (INHD): A Long-Term Follow-Up Study | July 2014 | December 2016 | |
| NCT02956811 | Completed | Phase 4 | Does Dapagliflozin Regress Left Ventricular Hypertrophy In Patients With Type 2 Diabetes? | February 14, 2017 | April 2, 2019 |
| NCT03182699 | Completed | Phase 4 | Effect of Etelcalcetide on Cardiac Hypertrophy in Hemodialysis Patients | October 1, 2017 | December 20, 2019 |
| NCT03186742 | Completed | Phase 4 | Reduction of Left Ventricular Hypertrophy After Eplerenone Therapy | July 1, 2014 | June 1, 2017 |
| NCT03219632 | Completed | Fimasartan on Hypertensive Cardiac Disease With Left Ventricular Hypertrophy Estimated by ECG | June 5, 2012 | May 30, 2017 | |
| NCT03322319 | Completed | N/A | Frequency of Cardiac Amyloidosis in the Caribbean's. (TEAM Amylose) | September 23, 2013 | January 18, 2016 |
| NCT03332745 | Completed | Mechanism of Decompensation Evaluation - Aortic Stenosis | September 3, 2018 | July 31, 2023 | |
| NCT03489993 | Completed | FGF23 and Angiotensin-(1-7) in Hypophosphatemia (GAP) | December 6, 2018 | December 23, 2020 | |
| NCT03666351 | Completed | Phase 4 | Study to Evaluate the Effect on Improvement of LVH by the Control of BP in Hypertension Patients With AV Disease | October 18, 2018 | July 25, 2022 |
| NCT03759002 | Completed | Association of Mean Platelet Volume and Cardiovascular Disease in Children With End Stage Renal Disease. | February 1, 2016 | June 15, 2018 | |
| NCT04275882 | Completed | Demographical and Clinical Profile of Patients With Left Ventricular Hypertrophy | February 14, 2020 | December 1, 2021 | |
| NCT04461041 | Completed | Phase 4 | Empagliflozin and Cardiac Remodelling in People Without Diabetes | April 1, 2021 | July 31, 2022 |
| NCT05373732 | Completed | N/A | Stress Reduction in the Prevention of Left Ventricular Hypertrophy | April 1996 | December 1998 |
| NCT00344903 | Completed | Dallas Heart Study 2: Return Clinic Visit for the Dallas Heart Study Cohort | September 2007 | December 2009 | |
| NCT00348686 | Completed | Phase 4 | Candesartan Effectiveness Study in Pro-B Type Natriuretic Peptides (BNP) | June 2006 | June 2008 |
| NCT00364260 | Completed | Phase 3 | A Safety and Efficacy Study for Epoetin Alfa in Pre-dialysis Subjects. | December 1997 | August 2003 |
| NCT05903313 | Enrolling by invitation | A Study to Evaluate Accuracy and Validity of the Chang Gung ECG Abnormality Detection Software | October 6, 2023 | February 28, 2024 | |
| NCT04929600 | Recruiting | Phase 4 | Sacubitril/Valsartan Versus Amlodipine in Hypertension and Left Ventricular Hypertrophy. | November 28, 2021 | December 2023 |
| NCT05179668 | Recruiting | Phase 2 | SGLT2 Inhibition in Hemodialysis | October 1, 2022 | September 30, 2025 |
| NCT05719337 | Recruiting | Multi-Modality Echocardiographic Techniques in Pathological Left Ventricular Hypertrophy Adults | January 1, 2023 | August 5, 2025 | |
| NCT05730309 | Recruiting | N/A | Point-of-care Ultrasound and Treatment Disparities for Left Ventricular Hypertrophy | October 15, 2023 | August 2025 |
| NCT03816462 | Recruiting | ReNEW Clinic Cohort Study | January 2015 | September 2030 | |
| NCT06169358 | Recruiting | Screening Patients With Fabry Disease in Patients With Hypertrophic Cardiomyopathy or Left Ventricular Hypertrophy | October 1, 2023 | September 1, 2024 | |
| NCT05942729 | Recruiting | Etiological DiagnOsis of caRdiac Diseases Based on echoCardiograpHIc Images and Clinical Data. | January 1, 2023 | January 1, 2027 | |
| NCT05593055 | Recruiting | Phase 4 | Mineralocorticoid Receptor, Coronary Microvascular Function, and Cardiac Efficiency in Hypertension | August 25, 2023 | December 31, 2026 |
| NCT05646056 | Recruiting | A Noninterventional, Single-Center Feasibility Study to Evaluate Measures of Heart Failure Risk | October 28, 2022 | March 31, 2024 | |
| NCT04644094 | Recruiting | Postnatal Steroids Effects on Cardiac Function in Extremely Preterm | June 15, 2021 | June 2025 | |
| NCT04752293 | Recruiting | Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE) | May 19, 2021 | December 2025 | |
| NCT05388032 | Recruiting | N/A | Sodium Lowering Vascular Effects Trial | January 25, 2023 | June 30, 2026 |
| NCT02670031 | Recruiting | Response of the Myocardium to Hypertrophic Conditions in the Adult Population | January 2016 | September 2031 | |
| NCT03193073 | Suspended | N/A | Anemia Correction and Fibroblast Growth Factor 23 Levels in Chronic Kidney Disease , and Renal Transplant Patient | September 1, 2018 | December 1, 2020 |
| NCT01199211 | Terminated | Impact of Physical Activity on Left Ventricular Mass and Lipid Metabolism | February 2011 | October 2017 | |
| NCT00582114 | Terminated | Phase 3 | Hypertension in Hemodialysis Patients (Aim 3) | August 2005 | September 2013 |
| NCT00175149 | Terminated | Phase 4 | Active Vitamin D Effect on Left Ventricular Hypertrophy | January 2002 | December 2008 |
| NCT01188369 | Terminated | Phase 4 | Effects of Levosimendan in Patients Eligible for Aortic Valve Replacement With Left Ventricular Hypertrophy | September 2010 | March 2013 |
| NCT01241838 | Terminated | N/A | The Effect of Heart Rate on Cardiac Index in Patients With Left Ventricular Hypertrophy | February 2011 | August 2012 |
| NCT01173666 | Unknown status | Phase 3 | Stenting of Renal Artery Stenosis in Coronary Artery Disease Study | April 2006 | April 2011 |
| NCT02493465 | Unknown status | Phase 4 | Effects of Everolimus in Left Ventricular Hypertrophy After Conversion From Azathioprine: A Pilot Study | July 2015 | July 2017 |
| NCT05002010 | Unknown status | Left Ventricular Hypertrophy Among Chronic Kidney Disease Patients in Assiut University Hospital | February 2022 | December 2022 | |
| NCT00418041 | Unknown status | Chronic Heart Failure Analysis and Registry in the Tohoku District 2 (CHART-2 Study) | October 2006 | December 2019 | |
| NCT02973633 | Unknown status | Early Phase 1 | Diffusion MRI in Heart Failure | June 30, 2017 | December 31, 2022 |
| NCT03040947 | Unknown status | MRI Sequence and Imaging Protocol Development | March 2016 | December 2022 | |
| NCT00871611 | Unknown status | Viennese Prevalence Study of Anderson-Fabry Disease | January 2009 | January 2012 | |
| NCT00294775 | Unknown status | Phase 3 | Effect of Angiotensin II Receptor Blockers (ARB) on Left Ventricular Reverse Remodelling After Aortic Valve Replacement in Severe Valvular Aortic Stenosis | February 2006 | June 2009 |
| NCT03549559 | Unknown status | N/A | Imaging Histone Deacetylase in the Heart | September 7, 2018 | July 1, 2023 |
| NCT01382966 | Unknown status | Serum Sclerostin Levels, Cardiovascular Parameters and Carpal Tunnel Syndrome in Maintenance Hemodialysis Patients | July 2011 | October 2011 | |
| NCT04022330 | Unknown status | N/A | Protective Monocytes and Macrophages to Limit Decompensation and Heart Damaging | October 15, 2019 | April 15, 2024 |
| NCT02221141 | Unknown status | Screening of Fabry Disease in Patients With Left Ventricular Hypertrophy Detected in Echocardiography | December 2013 | December 2022 |
- HPO alt_id (Human Phenotype Ontology)
- HP:0005171
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0001712
- MedGen concept unique identifier (MedGen Concept name)
- C0149721
- MedGen unique identifier (MedGen Concept name)
- 57442